πŸ‡ΊπŸ‡Έ FDA
Patent

US 10174039

P2X3 and/or P2X2/3 compounds and methods

granted A61PA61P11/00A61P11/06

Quick answer

US patent 10174039 (P2X3 and/or P2X2/3 compounds and methods) held by Asana BioSciences, LLC expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Asana BioSciences, LLC
Grant date
Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61P, A61P11/00, A61P11/06, A61P11/08, A61P25/00